Massive 10,000-Person study checks safety of new whooping cough vaccine
NCT ID NCT07444502
Summary
This study monitored the safety of the Boostagen vaccine, which protects against whooping cough, tetanus, and diphtheria, after it was approved for use in Thailand. Over 10,000 people, including children, adults, and pregnant women, received the vaccine as part of their regular medical care. Doctors and nurses across the country tracked any health problems that occurred after vaccination to ensure the vaccine is safe for the general public.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TETANUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
BioNet-Asia Co., Ltd.
Bangkok, 10260, Thailand
Conditions
Explore the condition pages connected to this study.